Suppr超能文献

斯威士兰孕妇和产后妇女对艾滋病毒口服暴露前预防药物的接受情况及使用意愿:一项横断面调查

Uptake of and intention to use oral pre-exposure prophylaxis for HIV among pregnant and post-natal women in Eswatini: a cross-sectional survey.

作者信息

Khumalo Philisiwe Ntombenhle, Mkhonta Siphiwesihle Sibonisiwe, Kindandi Kikanda, Matse Sindy, Dlamini Phinda Brian, Tukei Vincent, Machekano Rhoderick, Woelk Godfrey

机构信息

Strategic Information and Evaluation/Clinical Services Delivery Department, Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.

Eswatini National AIDS Program, Ministry of Health, Mbabane, Eswatini.

出版信息

Front Reprod Health. 2023 Oct 27;5:1253384. doi: 10.3389/frph.2023.1253384. eCollection 2023.

Abstract

INTRODUCTION

In Eswatini, HIV incidence among women of childbearing age is 1.45%. Eswatini introduced oral pre-exposure prophylaxis (PrEP) for HIV prevention in 2016 and requires that all HIV-negative pregnant and post-natal women (PPW) visiting health care facilities be offered PrEP.

METHODS

Between September-November 2021, we conducted a survey among HIV-negative PPW from 16 purposively selected healthcare facilities in the Hhohho and Shiselweni regions in Eswatini. We interviewed consenting HIV-negative PPW using a structured questionnaire to collect data on PrEP knowledge, attitudes, intentions, and practices, as well as information on partner HIV status and stigma. Multivariate logistic regression was used to determine predictors of PrEP use and intention, adjusted for significant covariates.

RESULTS

Of 1,484 PPW women approached, 1,149 consented and were interviewed, of whom 704 (61.3%) were post-partum and 445 (38.7%) pregnant. The median age was 25 years [Interquartile Range (IQR) = 21-30 years], with 533 (46.4%) 18-24 years old. Among the 1,149 women, 930 (80.7%) had ever heard about PrEP; 635 (55.3%) had knowledge about PrEP; 183 (15.9%) were currently using PrEP; and 285 (24.8%) had ever used PrEP. Increased odds of PrEP use were associated having HIV-positive male partner (aOR:7.76, 95%CI 3.53- 17.04); positive attitudes to PrEP (aOR:1.56, 95%CI: 1.02-2.40); and high self-efficacy (aOR:1.49, 95%CI:1.13-1.98). Among 864 women who never used PrEP, 569 (65.3%) intended to use PrEP in the future. Odds of intention to use PrEP were higher among women with low levels of education (aOR:2.23, 95% CI: 1.32-3.77); who ever heard about PrEP (aOR:1.69, 95%CI: 1.12-2.56); and had high self-efficacy (aOR:1.57, 95%CI: 1.31-1.87). Regarding stigma, among all women, 759 (66%) either agreed or strongly agreed that people would think they have HIV if they were to use PrEP; 658 (57.3%) reported they would be labelled as having multiple sex partners; 468 (40.7%) reported that their partner would think they are having risky sex with other people. Of 102 women who had discontinued PrEP, a majority stopped due to side effects 32 (35.2%).

CONCLUSION

Only about 50% of women had knowledge of PrEP, and PrEP uptake among PPW was low, though intention to use appeared high. More efforts to reduce stigma and promote PrEP use, including adequate information on side effects, are needed.

摘要

引言

在斯威士兰,育龄妇女的艾滋病毒感染率为1.45%。斯威士兰于2016年引入口服暴露前预防(PrEP)措施以预防艾滋病毒,并要求所有前往医疗机构就诊的艾滋病毒阴性孕妇和产后妇女(PPW)都能获得PrEP。

方法

在2021年9月至11月期间,我们对斯威士兰霍霍和希塞尔韦尼地区16家经过特意挑选的医疗机构中的艾滋病毒阴性PPW进行了一项调查。我们使用结构化问卷对同意参与的艾滋病毒阴性PPW进行访谈,以收集有关PrEP知识、态度、意图和实践的数据,以及关于伴侣艾滋病毒状况和耻辱感的信息。使用多变量逻辑回归来确定PrEP使用和意图的预测因素,并对显著的协变量进行调整。

结果

在1484名接触到的PPW妇女中,1149名同意参与并接受了访谈,其中704名(61.3%)为产后妇女,445名(38.7%)为孕妇。中位年龄为25岁[四分位间距(IQR)=21 - 30岁],其中533名(46.4%)年龄在18 - 24岁之间。在这1149名妇女中,930名(80.7%)曾经听说过PrEP;635名(55.3%)了解PrEP知识;183名(15.9%)目前正在使用PrEP;285名(24.8%)曾经使用过PrEP。PrEP使用几率增加与有艾滋病毒阳性男性伴侣相关(调整后的比值比:7.76,95%置信区间3.53 - 17.04);对PrEP持积极态度(调整后的比值比:1.56,95%置信区间:1.02 - 2.40);以及自我效能感高(调整后的比值比:1.49,95%置信区间:1.13 - 1.98)。在864名从未使用过PrEP的妇女中,569名(65.3%)打算在未来使用PrEP。教育程度低的妇女使用PrEP的意图几率更高(调整后的比值比:2.23,95%置信区间:1.32 - 3.77);曾经听说过PrEP的妇女(调整后的比值比:1.69,95%置信区间:1.12 - 2.56);以及自我效能感高的妇女(调整后的比值比:1.57,95%置信区间:1.31 - 1.87)。关于耻辱感,在所有妇女中,759名(66%)同意或强烈同意如果她们使用PrEP人们会认为她们感染了艾滋病毒;658名(57.3%)报告说她们会被贴上有多个性伴侣的标签;468名(40.7%)报告说她们的伴侣会认为她们与其他人进行危险性行为。在102名停止使用PrEP的妇女中,大多数(32名,35.2%)是因为副作用而停药。

结论

只有约50%的妇女了解PrEP,PPW中PrEP的使用率较低,尽管使用意图似乎较高。需要做出更多努力来减少耻辱感并促进PrEP的使用,包括提供关于副作用的充分信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c244/10641516/ca8d70a9bd71/frph-05-1253384-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验